Skip to main content
Molecular Brain logoLink to Molecular Brain
. 2021 Jul 8;14:108. doi: 10.1186/s13041-021-00816-4

Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

Chunni Zhu 1,#, Tina Bilousova 1,2,#, Samantha Focht 1, Michael Jun 1, Chris Jean Elias 1, Mikhail Melnik 1, Sujyoti Chandra 1, Jesus Campagna 1, Whitaker Cohn 1, Asa Hatami 1, Patricia Spilman 1, Karen Hoppens Gylys 2, Varghese John 1,
PMCID: PMC8265003  PMID: 34238327

Correction to: Mol Brain (2021) 14:70 https://doi.org/10.1186/s13041-021-00776-9

Following publication of the original article [1], it was noted that due to a typesetting mistake, an incorrect version of Additional file 1 (with regards to the reference numbering) was processed.

The correct version of Additional file 1 is attached to this Correction and has been corrected in the original article. The publisher apologises to the authors and readers for the inconvenience caused by this error.

Supplementary Information

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Chunni Zhu and Tina Bilousova contributed equally to the manuscript

Reference

  • 1.Zhu C, Bilousova T, Focht S, Jun M, Elias CJ, Melnik M, Chandra S, Campagna J, Cohn W, Hatami A, Spilman P, Gylys KH, John V. Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model. Mol Brain. 2021;14:70. doi: 10.1186/s13041-021-00776-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Molecular Brain are provided here courtesy of BMC

RESOURCES